Japan Encephalitis Vaccines Market Analysis

Japan Encephalitis Vaccines Market Analysis


$ 3999

Japan Encephalitis Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of encephalitis, growing awareness and immunization programs, technological advancements in vaccine development, global travel and migration, and government support and funding are the drivers of the encephalitis vaccines market. GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Merck & Co., Novartis AG, Bharat Biotech International Ltd., Takeda Pharmaceutical Company Limited, Biological E. Limited, Valneva SE and Sinovac Biotech Ltd are global companies in encephalitis vaccines market.

ID: IN10JPPH275 CATEGORY: Pharmaceuticals GEOGRAPHY: Japan AUTHOR: Aneri Parekh

Buy Now

Japan Encephalitis Vaccines Market Analysis Summary

Japan Encephalitis Vaccines Market is valued at around $1030.6 Mn in 2022 and is projected to reach $2004.2 Mn by 2030, exhibiting a CAGR of 8.67% during the forecast period 2023-2030.

Encephalitis vaccinations are immunizations that protect against specific microorganisms that cause encephalitis, such as the Japanese encephalitis virus and tick-borne encephalitis virus. These vaccines stimulate the immune system to produce a protective response, lowering the risk of encephalitis and its complications. The encephalitis vaccine market is being driven by rising encephalitis prevalence, increased awareness, and immunization programs, technological improvements in vaccine development, global travel and migration, and government support and financing. GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Merck & Co., Novartis AG, Bharat Biotech International Ltd., Takeda Pharmaceutical Company Limited, Biological E. Limited, Valneva SE, and Sinovac Biotech Ltd are global companies in encephalitis vaccines market.

Market Dynamics

Market Growth Drivers

  1. Rising encephalitis cases: Rising encephalitis cases, including viral encephalitis caused by diverse infections, stimulate vaccination need
  2. Increasing public awareness and immunization programs: Increased vaccine awareness, as well as government actions to promote immunization, contribute to market growth
  3. Advances in vaccine development technology: Advances in vaccine research and development, including new antigen formulations and adjuvants, promote market expansion
  4. Global travel and migration: International travel and migration raise the risk of encephalitis-causing pathogen exposure, necessitating vaccination
  5. Government support and funding: Government policies that encourage vaccination programs, as well as the inclusion of encephalitis vaccines on national immunization schedules, drive market growth

Market Restraints

  1. Sophisticated manufacturing and distribution processes: Vaccine manufacture and distribution necessitate tight quality control, cold chain maintenance, and complex logistics, all of which pose difficulties
  2. Vaccine hesitation: Vaccine hesitancy, which is caused by misinformation and safety concerns, may impede vaccine adoption and have an impact on market growth
  3. High vaccine and immunization program costs can be prohibitively expensive, especially in low-resource contexts, limiting market penetration
  4. Inadequate accessibility and healthcare infrastructure: Inadequate healthcare infrastructure, particularly in rural regions, may impede vaccine access and limit market expansion

Competitive Landscape

Key Players

  • GlaxoSmithKline plc
  • Sanofi Pasteur
  • Pfizer Inc.
  • Merck & Co.
  • Novartis AG
  • Bharat Biotech International Ltd.
  • Takeda Pharmaceutical Company Limited
  • Biological E. Limited
  • Valneva SE
  • Sinovac Biotech Ltd.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Japan Encephalitis Vaccines Market Segmentation

By Vaccine Type

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

By Target Pathogens

  • Japanese Encephalitis Virus
  • Tick-borne Encephalitis Virus
  • Herpes Simplex Virus
  • Enteroviruses (e.g., Poliovirus, Coxsackievirus)
  • Other Encephalitis-causing Pathogens

By Age Group

  • Pediatric Vaccines
  • Adult Vaccines

By End User

  • Hospitals
  • Clinics
  • Pharmacy

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up